Benefits of prophylactic voice prosthesis replacement: a retrospective study
IntroductionIn this retrospective, single-center study conducted at a regional cancer center, we have analyzed whether prophylactic voice prosthesis replacement (PVPR) could reduce the occurrence of tracheoesophageal fistula (TEF) dysfunction.MethodsWe reviewed 2,431 cases of voice prosthesis (VP) r...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1566697/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839655833710886912 |
|---|---|
| author | Sławomir Okła Sławomir Okła Jakub Spałek Jakub Spałek Szczepan Kaliniak Agnieszka Strzelecka Michał Chrobot Paweł Macek Paweł Macek Michiel W. van den Brekel Stanisław Góźdź Stanisław Góźdź |
| author_facet | Sławomir Okła Sławomir Okła Jakub Spałek Jakub Spałek Szczepan Kaliniak Agnieszka Strzelecka Michał Chrobot Paweł Macek Paweł Macek Michiel W. van den Brekel Stanisław Góźdź Stanisław Góźdź |
| author_sort | Sławomir Okła |
| collection | DOAJ |
| description | IntroductionIn this retrospective, single-center study conducted at a regional cancer center, we have analyzed whether prophylactic voice prosthesis replacement (PVPR) could reduce the occurrence of tracheoesophageal fistula (TEF) dysfunction.MethodsWe reviewed 2,431 cases of voice prosthesis (VP) replacement procedures performed in 327 patients between January 2017 and December 2022 at the Department of Otolaryngology, Head and Neck Surgery, Holy Cross Cancer Centre, Kielce, Poland. In the middle of this period (January 2020), the management of VP replacements was changed from reactive, unscheduled voice prosthesis replacement (UVPR), with a median device lifetime of 7 months, to prophylactic, scheduled replacement (PVPR) procedures occurring every 3 months.ResultsThe statistical analysis confirmed a significantly lower number of complications during the period of PVPR (2020–2022) compared to the previous period of UVPR (2017–2019). In the years 2017–2019, out of a total of 911 voice prosthesis replacements performed in 246 patients, 425 were associated with complications related to TEF (47%). In comparison, in the years 2020–2022 (following the introduction of PVPR), only 91 cases (6%) (p<0.001; r = 0.408) out of 1,520 voice prosthesis exchanges performed in 250 patients had related TEF complications. The types and occurrence of TEF complications remained the same in both time intervals (UVPR vs. PVPR), with widening of the fistula tract being the most common, comprising 80% and 78% of all TEF complications, respectively.DiscussionPVPR every 3 months can reduce fistula complications compared to a protocol with reactive replacement for voice prosthesis or TEF dysfunction. |
| format | Article |
| id | doaj-art-1e55be0fdd2e47ea9f0be2aae84f6718 |
| institution | Matheson Library |
| issn | 2234-943X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj-art-1e55be0fdd2e47ea9f0be2aae84f67182025-06-25T05:24:02ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-06-011510.3389/fonc.2025.15666971566697Benefits of prophylactic voice prosthesis replacement: a retrospective studySławomir Okła0Sławomir Okła1Jakub Spałek2Jakub Spałek3Szczepan Kaliniak4Agnieszka Strzelecka5Michał Chrobot6Paweł Macek7Paweł Macek8Michiel W. van den Brekel9Stanisław Góźdź10Stanisław Góźdź11Institute of Medical Science, Collegium Medicum, Jan Kochanowski University of Kielce, Kielce, PolandDepartment of Otolaryngology, Head and Neck Surgery, Holy-Cross Cancer Center, Kielce, PolandInstitute of Medical Science, Collegium Medicum, Jan Kochanowski University of Kielce, Kielce, PolandDepartment of Otolaryngology, Head and Neck Surgery, Holy-Cross Cancer Center, Kielce, PolandDepartment of Otolaryngology, Head and Neck Surgery, Holy-Cross Cancer Center, Kielce, PolandInstitute of Health Science, Collegium Medicum, Jan Kochanowski University of Kielce, Kielce, PolandDepartment of Otolaryngology, Head and Neck Surgery, Holy-Cross Cancer Center, Kielce, PolandInstitute of Medical Science, Collegium Medicum, Jan Kochanowski University of Kielce, Kielce, PolandScientific Research, Epidemiology and R&D Centre, Holy-Cross Cancer Centre, Kielce, PolandDepartment of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, NetherlandsInstitute of Medical Science, Collegium Medicum, Jan Kochanowski University of Kielce, Kielce, PolandDepartment of Otolaryngology, Head and Neck Surgery, Holy-Cross Cancer Center, Kielce, PolandIntroductionIn this retrospective, single-center study conducted at a regional cancer center, we have analyzed whether prophylactic voice prosthesis replacement (PVPR) could reduce the occurrence of tracheoesophageal fistula (TEF) dysfunction.MethodsWe reviewed 2,431 cases of voice prosthesis (VP) replacement procedures performed in 327 patients between January 2017 and December 2022 at the Department of Otolaryngology, Head and Neck Surgery, Holy Cross Cancer Centre, Kielce, Poland. In the middle of this period (January 2020), the management of VP replacements was changed from reactive, unscheduled voice prosthesis replacement (UVPR), with a median device lifetime of 7 months, to prophylactic, scheduled replacement (PVPR) procedures occurring every 3 months.ResultsThe statistical analysis confirmed a significantly lower number of complications during the period of PVPR (2020–2022) compared to the previous period of UVPR (2017–2019). In the years 2017–2019, out of a total of 911 voice prosthesis replacements performed in 246 patients, 425 were associated with complications related to TEF (47%). In comparison, in the years 2020–2022 (following the introduction of PVPR), only 91 cases (6%) (p<0.001; r = 0.408) out of 1,520 voice prosthesis exchanges performed in 250 patients had related TEF complications. The types and occurrence of TEF complications remained the same in both time intervals (UVPR vs. PVPR), with widening of the fistula tract being the most common, comprising 80% and 78% of all TEF complications, respectively.DiscussionPVPR every 3 months can reduce fistula complications compared to a protocol with reactive replacement for voice prosthesis or TEF dysfunction.https://www.frontiersin.org/articles/10.3389/fonc.2025.1566697/fullvoice prosthesis (VP)prophylactic VP replacementTE fistula wideningdevice lifetimecomplicationlaryngectomy |
| spellingShingle | Sławomir Okła Sławomir Okła Jakub Spałek Jakub Spałek Szczepan Kaliniak Agnieszka Strzelecka Michał Chrobot Paweł Macek Paweł Macek Michiel W. van den Brekel Stanisław Góźdź Stanisław Góźdź Benefits of prophylactic voice prosthesis replacement: a retrospective study Frontiers in Oncology voice prosthesis (VP) prophylactic VP replacement TE fistula widening device lifetime complication laryngectomy |
| title | Benefits of prophylactic voice prosthesis replacement: a retrospective study |
| title_full | Benefits of prophylactic voice prosthesis replacement: a retrospective study |
| title_fullStr | Benefits of prophylactic voice prosthesis replacement: a retrospective study |
| title_full_unstemmed | Benefits of prophylactic voice prosthesis replacement: a retrospective study |
| title_short | Benefits of prophylactic voice prosthesis replacement: a retrospective study |
| title_sort | benefits of prophylactic voice prosthesis replacement a retrospective study |
| topic | voice prosthesis (VP) prophylactic VP replacement TE fistula widening device lifetime complication laryngectomy |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2025.1566697/full |
| work_keys_str_mv | AT sławomirokła benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT sławomirokła benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT jakubspałek benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT jakubspałek benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT szczepankaliniak benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT agnieszkastrzelecka benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT michałchrobot benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT pawełmacek benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT pawełmacek benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT michielwvandenbrekel benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT stanisławgozdz benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy AT stanisławgozdz benefitsofprophylacticvoiceprosthesisreplacementaretrospectivestudy |